Study of Safety and Efficacy of an Oral Contraceptive

Completed · Phase 3 · Has a placebo group

Conditions studied: Prevention of Pregnancy

In brief

This is a comparative study. The primary objective of the study is to assess the efficacy of a low dose oral contraceptive in the prevention of pregnancy. The secondary objectives are to assess the incidence of intracyclic bleeding of norethindrone acetate/ethinyl estradiol (NETA/EE) administered for 24 days and NETA/EE administered for 21 days; and to assess the safety and tolerability of the product.

Key facts

Study ID
NCT00932321
Run by
Warner Chilcott
People needed
938
Starts
2004-01-01
Expected to finish
2004-11-01
Last updated by the study team
2013-04-22

Who can join

Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.